Global Biopsy Devices Market By Overview
Biopsy is a surgical procedure used for the removal of tissue from an organ. It determines the presence or extent of a disease. It is performed by either radiologists or surgeons and even interventional cardiologists. Biopsies can be performed on any organ using specific biopsy devices. Biopsies act as a confirmatory test for cancer and celiac diseases. The biopsy devices market accounted for US$ 181.47 billion in 2020 and is estimated to be US$ 869.6 billion by 2030 and is anticipated to register a CAGR of 8.9%.
Global Biopsy Devices Market By Drivers & Restraints
Increasing incidence of various types of cancer
Increasing incidence of various types of cancer, coupled with high awareness among the general population about chronic diseases in developed and developing economies are key factors driving growth of the global biopsy devices market. In addition, rising demand for minimally invasive procedures, and need for early diagnosis and treatment for chronic diseases are major factors expected to fuel growth to the global biopsy devices market over the forecast period. According to a data published by America Cancer Society Organization in 2019, in the US, approximately 39 out of 100 men and 38 out of 100 women will develop cancer during their lifetime.
Global Biopsy Devices Market By Segmentations & Regional Insights
.
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report
The global biopsy devices market report segments the market on the basis of device type, imaging technology, application, end-user, and region.
On the basis of Device Type, the global biopsy devices market is segmented into Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and Other devices. On the basis of Imaging Technology, the target market is segmented into CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and others. Based on Application the market is segmented into Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others. Based on End User the market is segmented into Diagnostics and Hospitals.
Regional Insights:
Source: Prophecy Market Insights
On region the global biopsy devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global biopsy devices market in revenue terms owing to availability of appropriate equipment and infrastructure, high awareness among the general population about chronic disease diagnosis and treatment, and increasing incidence of chronic diseases in the region. Europe is currently the second-highest market in the global biopsy devices market, owing to increasing healthcare expenditure by governments of countries in the region, and relatively high disposable income among the general population.
Report Scope:
Attribute |
Details |
Base year for estimation |
2020 |
Forecast period |
2020 – 2029 |
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
Market Segmentation |
By Device Type - Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and Other devices By Imaging Technology – CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and Others By Application – Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others By End User – Diagnostics and Hospitals |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global biopsy devices market report based on Device Type, Imaging Technology, Application, End User and Region.
Global biopsy devices market, By Region:
- North America
-
-
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
-
-
Global Biopsy Devices Market By Competitive Landscape & Key Players
Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global biopsy devices market. Key players have adopted mergers & acquisitions and new product developments to strengthen their positions in the global biopsy devices market. Major Key players of the market includes Bard Inc., Leica Biosystems, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Medtronic and Argon Medical Devices Inc.
Global Biopsy Devices Market By Company Profile
- Bard Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Leica Biosystems
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Dickinson and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Ethicon EndoSurgery Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fujifilm Medical Systems
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Veran Medical Technologies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- MDxHealth
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Medtronic
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Argon Medical Devices Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Biopsy Devices Market By Highlights
FAQs
The global biopsy devices market report segments the market on the basis of device type, imaging technology, application, end-user, and region.
Increasing incidence of various types of cancer, coupled with high awareness among the general population about chronic diseases in developed and developing economies are key factors driving growth of the global biopsy devices market.
North America dominates the global biopsy devices market in revenue terms owing to availability of appropriate equipment and infrastructure, high awareness among the general population about chronic disease diagnosis and treatment, and increasing incidence of chronic diseases in the region.
Key players in this market are Bard Inc., Leica Biosystems, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Medtronic and Argon Medical Devices Inc.